Consumer Driven Health Care

The new dispute resolution process is designed to use government officials to oversee disagreements, however, lobby group PhRMA said the new process "panders to 340B hospitals" while ignoring drugmakers' concerns.

Eli Lilly had agreed to cap the price of insulin at $35 per month for 4 years and provide a $13.5 million cash fund, however, a dozen state attorneys general, some with their own insulin lawsuits, had objected to the settlement.

Elevance Health, which is the parent company of Blue Cross and Blue Shield Health insurance plans in 14 states, has partnered with a private equity firm, forging a new offering that will take a whole health approach to primary care.

The health fund for the International Union of Operating Engineers is suing Eli Lilly, Novo Nordisk and Sanofi, as well as CVS Health and other PBMs, for "drastically" increasing the price of life-saving meds for "illicit profits."

In the first quarter of 2024, 323 drugs were in short supply, up from the previous high of 320 in 2014, says the University of Utah Drug Information Service, as policymakers propose giving the FDA more power over Big Pharma.

For the first time, UnitedHealth acknowledged that it paid ransom to "protect patient data," even though the feds have asked health-care organizations not to pay ransom so stealing patient data becomes less lucrative.